Drawing for RED CAP PHARMACY

USPTO serial 86936106

RED CAP PHARMACY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FERRELL, STEVEN WAYNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RED CAP PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, inhalants, sachets and pharmaceutical preparations and substances for the prevention and treatment of diseases, conditions, and disorders, all for the prevention and treatment of respiratory, cardiovascular, and eye diseases, conditions, and disorders; Pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculo-skeletal, osteoporosis, cardiovascular, cardiopulmonary, heart rhythm, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ocular, respiratory, inflammatory, hematology, neurological, gastrointestinal, kidney, hormonal, dermatological, psychiatric, autoimmune, immune, and nervous system related diseases, conditions, and disorders; Pharmaceutical preparations and substances for use in chemotherapy and for the treatment of cancer; Pharmaceutical preparations and substances, namely, antidepressants; Pharmaceutical preparations and substances for the treatment of diseases, conditions, and disorders, namely, for the treatment of diabetes; Pharmaceutical preparations and substances for diseases, conditions, and disorders, all for ocular and intraocular surgery; Pharmaceutical preparations and substances for the prevention and treatment of diseases, conditions, and disorders, namely, for use in dermatology and skin care and for treating skin conditions and disorders; Pharmaceutical preparations and substances for the treatment and relief of back pain, muscle pain, arthritis, and joint pain; Pharmaceutical preparations, namely, cough and cold preparations, sinus preparations, and sleep aids; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for use in urology; Pharmaceutical preparations and substances for the prevention and treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, and antifungal preparations and vaccines; and Pharmaceutical preparations and substances for the prevention and treatment of infectious diseases, blood disorders, coagulation, pain, inflammation, sepsis, alopecia, obesity, and cognitive disorders, conditions, and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2017WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Dec 11, 2017WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Nov 6, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 6, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 28, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2017EX1GSOU EXTENSION 1 GRANTED—
Mar 25, 2017EXT1SOU EXTENSION 1 FILED—
Mar 25, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 25, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 4, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 9, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 9, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 27, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jun 24, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 24, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 24, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 22, 2016DOCKASSIGNED TO EXAMINER—
May 7, 2016TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
May 7, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 6, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 31, 2016ALIEASSIGNED TO LIE—
Mar 19, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 16, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance